NDC 68180-288

Abacavir and Lamivudine

Abacavir And Lamivudine

Abacavir and Lamivudine is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Lupin Pharmaceuticals, Inc.. The primary component is Abacavir Sulfate; Lamivudine.

Product ID68180-288_46fc1849-f45d-4eb7-af55-5e250b274087
NDC68180-288
Product TypeHuman Prescription Drug
Proprietary NameAbacavir and Lamivudine
Generic NameAbacavir And Lamivudine
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2017-03-28
Marketing CategoryANDA / ANDA
Application NumberANDA204990
Labeler NameLupin Pharmaceuticals, Inc.
Substance NameABACAVIR SULFATE; LAMIVUDINE
Active Ingredient Strength600 mg/1; mg/1
Pharm ClassesCytochrome P450 1A1 Inhibitors [MoA], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 68180-288-06

30 TABLET, FILM COATED in 1 BOTTLE (68180-288-06)
Marketing Start Date2017-03-28
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 68180-288-33 [68180028833]

Abacavir and Lamivudine TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA204990
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-03-28

NDC 68180-288-09 [68180028809]

Abacavir and Lamivudine TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA204990
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-03-28

NDC 68180-288-06 [68180028806]

Abacavir and Lamivudine TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA204990
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2017-03-28

Drug Details

Active Ingredients

IngredientStrength
ABACAVIR SULFATE600 mg/1

OpenFDA Data

SPL SET ID:1d8e7bb9-8624-4739-9719-fe25109d6365
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 602393
    • UPC Code
  • 0368180288060

    • Pharmacological Class

    • Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
    • Nucleoside Analog [EXT]
    • Nucleoside Reverse Transcriptase Inhibitors [MoA]
    • Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
    • Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
    • Nucleoside Analog [EXT]
    • Nucleoside Reverse Transcriptase Inhibitors [MoA]

    Medicade Reported Pricing

    68180028806 ABACAVIR-LAMIVUDINE 600-300 MG

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Abacavir and Lamivudine" or generic name "Abacavir And Lamivudine"

    NDCBrand NameGeneric Name
    0093-5382Abacavir and LamivudineAbacavir and Lamivudine
    35573-402Abacavir and LamivudineAbacavir and Lamivudine
    35573-430Abacavir and LamivudineAbacavir and Lamivudine
    42291-115Abacavir and LamivudineAbacavir and Lamivudine
    42385-962Abacavir and LamivudineAbacavir and Lamivudine
    65862-335Abacavir and LamivudineAbacavir and Lamivudine
    65862-900Abacavir and LamivudineAbacavir and Lamivudine
    66993-482Abacavir and Lamivudineabacavir sulfate and lamivudine
    68180-288Abacavir and LamivudineAbacavir and Lamivudine
    69097-362Abacavir and LamivudineAbacavir and lamivudine
    70518-0715Abacavir and LamivudineAbacavir and Lamivudine
    70710-1049Abacavir and lamivudineAbacavir and lamivudine
    70771-1053Abacavir and lamivudineAbacavir and lamivudine
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.